Study on clinical efficacy of tiotropium bromide combined with seretide in treatment of patients with chronic obstructive pulmonary disease
Lan Fe
Abstract
Lan Fe
Abstract
Objective To explore the clinical efficacy of tiotropium bromide combined with seretide in treatment of patients with chronic obstructive pulmonary disease.Methods A total of 60 patients with COPD were randomly divided into two groups.Tiotropium bromide combined with seretide were used in patients of observation group and seretide was used alone in patients of control group.FEV1,FEV1 / FVC,PO2,PCO2 and symptom scores were compared between these two groups.Results FEV1,FEV1 / FVC and PO2in patients of observation group were significantly higher than those of patients in control group,but PCO2and symptom scores of patients in observation group were significantly lower than those of patients in control group,and the difference between these two groups was significant(P 0.05).Conclusion The application of tiotropium bromide combined with seretide in treatment of patients with chronic obstructive pulmonary disease can improve the lung function and life quality of these patients,hence it is worthy to be clinically promoted.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To explore the clinical efficacy of tiotropium bromide combined with seretide in treatment of patients with chronic obstructive pulmonary disease.Methods A total of 60 patients with COPD were randomly divided into two groups.Tiotropium bromide combined with seretide were used in patients of observation group and seretide was used alone in patients of control group.FEV1,FEV1 / FVC,PO2,PCO2 and symptom scores were compared between these two groups.Results FEV1,FEV1 / FVC and PO2in patients of observation group were significantly higher than those of patients in control group,but PCO2and symptom scores of patients in observation group were significantly lower than those of patients in control group,and the difference between these two groups was significant(P 0.05).Conclusion The application of tiotropium bromide combined with seretide in treatment of patients with chronic obstructive pulmonary disease can improve the lung function and life quality of these patients,hence it is worthy to be clinically promoted.
Key concepts: Medicine, Tiotropium bromide, Pulmonary disease, COPD, Internal medicine, Clinical efficacy, Pulmonary function testing, Lung function